NerFarma S.R.L. (manufacturer (production of unpackaged drug, primary and secondary packaging, quality control, batch release))

The drug is intended for the treatment of adult patients with relapsing forms of multiple sclerosis (MS) with high disease activity, confirmed clinically or by examination results.

Dosage form: tablets

ATC: L04AA40